The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
United States Health Care Reform: Progress to Date and Next Steps
Open accessAbstract
IMPORTANCE: The Affordable Care Act is the most important health care legislation enacted in the United States since the creation of Medicare and Medicaid in 1965. The law implemented comprehensive reforms designed to improve the accessibility, affordability, and quality of health care. OBJECTIVES: To review the factors influencing the decision to pursue health reform, summarize evidence on the effects of the law to date, recommend actions that could improve the health care system, and identify general lessons for public policy from the Affordable Care Act. EVIDENCE: Analysis of publicly available data, data obtained from government agencies, and published research findings. The period examined extends from 1963 to early 2016. FINDINGS: The Affordable Care Act has made significant progress toward solving long-standing challenges facing the US health care system related to access, affordability, and quality of care. Since the Affordable Care Act became law, the uninsured rate has declined by 43%, from 16.0% in 2010 to 9.1% in 2015, primarily because of the law's reforms. Research has documented accompanying improvements in access to care (for example, an estimated reduction in the share of nonelderly adults unable to afford care of 5.5 percentage points), financial security (for example, an estimated reduction in debts sent to collection of $600-$1000 per person gaining Medicaid coverage), and health (for example, an estimated reduction in the share of nonelderly adults reporting fair or poor health of 3.4 percentage points). The law has also begun the process of transforming health care payment systems, with an estimated 30% of traditional Medicare payments now flowing through alternative payment models like bundled payments or accountable care organizations. These and related reforms have contributed to a sustained period of slow growth in per-enrollee health care spending and improvements in health care quality. Despite this progress, major opportunities to improve the health care system remain. CONCLUSIONS AND RELEVANCE: Policy makers should build on progress made by the Affordable Care Act by continuing to implement the Health Insurance Marketplaces and delivery system reform, increasing federal financial assistance for Marketplace enrollees, introducing a public plan option in areas lacking individual market competition, and taking actions to reduce prescription drug costs. Although partisanship and special interest opposition remain, experience with the Affordable Care Act demonstrates that positive change is achievable on some of the nation's most complex challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The quality of health care delivered to adults in the United States
McGlynn, E. A., Asch, S. M., Adams, J., Keesey, J., Hicks, J., DeCristofaro, A., & Kerr, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa022615 · Cited by 5,079
Fisher, E. S., Wennberg, D. E., Stukel, T. A., Gottlieb, D. J., Lucas, F. L., & Pinder, É. L. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-4-200302180-00006 · Cited by 1,539
Fisher, E. S., Wennberg, D. E., Stukel, T. A., Gottlieb, D. J., Lucas, F. L., & Pinder, É. L. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-4-200302180-00007 · Cited by 1,341
The Oregon Experiment — Effects of Medicaid on Clinical Outcomes
Baicker, K., Taubman, S. L., Allen, H. L., Bernstein, M., Gruber, J. H., Newhouse, J. P., Schneider, E. C., Wright, B. J., Zaslavsky, A. M., & Finkelstein, A. N. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1212321 · Cited by 1,150
Readmissions, Observation, and the Hospital Readmissions Reduction Program
Zuckerman, R. B., Sheingold, S. H., Orav, E. J., Ruhter, J., & Epstein, A. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmsa1513024 · Cited by 826
The Economic Report of the President.
(1955) · Journal of the American Statistical Association · doi:10.2307/2281111 · Cited by 665
Sommers, B. D., Gunja, M. Z., Finegold, K., & Musco, T. (2015) · JAMA · doi:10.1001/jama.2015.8421 · Cited by 655
Mortality and Access to Care among Adults after State Medicaid Expansions
Sommers, B. D., Baicker, K., & Epstein, A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmsa1202099 · Cited by 578
Courtemanche, C., Marton, J., Ukert, B., Yelowitz, A., & Zapata, D. (2017) · Journal of Policy Analysis and Management · doi:10.1002/pam.21961 · Cited by 370
Quality of Health Care Delivered to Adults in the United States
(2003) · New England Journal of Medicine · doi:10.1056/nejm200311063491916 · Cited by 318
Cited by
Health Care Spending in the United States and Other High-Income Countries
Papanicolas, I., Woskie, L. R., & Jha, A. K. (2018) · JAMA · doi:10.1001/jama.2018.1150 · Cited by 1,626
Progress on catastrophic health spending in 133 countries: a retrospective observational study
Wagstaff, A., Flores, G., Hsu, J., Smitz, M.-F., Chepynoga, K., Buisman, L. R., van Wilgenburg, K., & Eozenou, P. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30429-1 · Cited by 1,019
Essential medicines for universal health coverage
Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., Gyansa-Lutterodt, M., Jing, S., Luiza, V. L., Mbindyo, R. M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31599-9 · Cited by 661
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform
Kesselheim, A. S., Avorn, J., & Sarpatwari, A. (2016) · JAMA · doi:10.1001/jama.2016.11237 · Cited by 592
Progress on impoverishing health spending in 122 countries: a retrospective observational study
Wagstaff, A., Flores, G., Smitz, M.-F., Hsu, J., Chepynoga, K., & Eozenou, P. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30486-2 · Cited by 421
Metadata
- Authors
- Obama, B.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-08-02
- Volume
- 316
- Issue
- 5
- Pages
- 525
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2461593871
- Cited by
- 676
- References
- 26
- FWCI
- 250.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: United States Health Care Reform: Progress to Date and Next Steps. https://app.cochat.ai/papers/10.1001/jama.2016.9797
- The paper
- Obama, B. (2016). United States Health Care Reform: Progress to Date and Next Steps. JAMA. https://doi.org/10.1001/jama.2016.9797
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.